# q01 rev 0 - blind solver A (fresh blind-solver, packet solver-1), 2026-10-06

Raw return as received:

I didn't read question.txt or any notes. Nothing leaked from the caller.

    answer: Flat. The guidance in force in April 2026 (issued February 4, 2026) projected flat fiscal 2026 adjusted operating income, about 0% growth, for "Other", the group that included U.S. Consulting Services. The fiscal 2025 base was $352M.
    confidence: high
    path:
     1. When it was divested. D05 (Q3 FY26 release, Aug 5, 2026), line 81: "These businesses include MWI Animal Health, Profarma, U.S. Consulting Services (which was divested in April 2026)". Line 95 says "the April 2026 divestiture of U.S. Consulting Services", and footnotes at lines 269 and 393 say "which was divested in April 2026."
     2. Which group held it. D05 line 81, D01 line 81 and D03 line 86 all say "other businesses for which the Company is exploring strategic alternatives have been grouped together in Other." D06 line 121 sets this up from Q1 FY26: "Other ... includes MWI Animal Health, Profarma, U.S. Consulting Services and the other components of PharmaLex." The same line moves it out of U.S. Healthcare Solutions ("excluding legacy U.S. Consulting Services").
     3. Guidance in force in April 2026. D01 (Feb 4, 2026), adjusted operating income block at lines 111–114, row 114: "|Other(2)|Flat|$352M|". This is not the revenue row at line 110 ("|Other(2)|1% to 5% growth|$8.2B|"). D01 line 103 gives the reason: "improved results in Other as certain depreciable assets have been fully impaired as of December 31, 2025."
     4. Nothing replaced it before April. The next update came on May 6, 2026 (D03), which is after April. D03 line 17 says EPS guidance "has been raised from the previous range of $17.45 to $17.75". That is exactly D01's range, so no update happened in between. D03 line 112 says this release brings "updated operating income expectations in Other as a result of MWI now being accounted for as 'held for sale'", and its line 123 now reads "|Other(2)|High-single digit growth|$352M|".
     5. Full timeline for Other's adjusted operating income guidance:
        - Nov 5, 2025 (D06 line 138): "1% to 4% decline"
        - Feb 4, 2026 (D01): "Flat". This was in force in April 2026.
        - May 6, 2026 (D03): "High-single digit growth"
        - Aug 5, 2026 (D05 line 118): "~10% growth"
     No calculation was needed. Flat on a $352M base means about $352M, or 0% growth.
    minimal_documents: D01 and D05. D01 gives the "Flat" figure. D05 is the only document that dates the divestiture to April 2026; D03 does not mention it. D03 is supporting evidence that the guidance was not updated between Feb 4 and May 6, 2026. D06 only adds history and the definition of Other. D02 and D04 cover fiscal 2025 guidance only and are not relevant.
    readings:
     - "Then-current" could be read as the first guidance issued after the divestiture (D03, May 6, 2026). That gives "High-single digit growth". It is weaker, because that guidance came after the April divestiture.
     - It could also be read as the guidance in the release that first reported the divestiture (D05, Aug 5, 2026). That gives "~10% growth".
     - If "divested" meant when the business was first classified as held for sale (D01 line 47, by December 31, 2025), the guidance in force was D06's "1% to 4% decline". This doesn't fit the ordinary meaning of "divested".
    gaps:
     - The packet gives only "April 2026" for the divestiture, not an exact closing date.
     - Guidance changes made outside earnings releases aren't in the packet. One clearly exists: D05 line 17 cites a "previous range of $17.70 to $17.90", which differs from D03's $17.65–$17.90. That change happened after May 6, so it doesn't affect April. For Feb–May, D03's "previous range" matches D01.
     - The note "Bolded figures indicate updates to guidance metrics" can't be checked, because the documents are text only (no PDF, pages null).
     - Not fully read:
       - D03 after line 269 (reconciliation, segment and balance-sheet tables)
       - D05 after line 709 (end of the non-GAAP notes)
       - D06 after line 200 (fiscal 2025 tables)
       - D02 and D04, which I only searched
       - the docs/ copies, which I only searched to confirm the guidance rows
    contaminated: no

Files:
- D:\Dev\Docket\tasks\aq-01322\runs\q01-r0-v2-e9943e281c4c3ad83064f87cbd3df1e814b37a90c5c548a257d5cd36df6293f9\solver-1\text\D01.txt
- D:\Dev\Docket\tasks\aq-01322\runs\q01-r0-v2-e9943e281c4c3ad83064f87cbd3df1e814b37a90c5c548a257d5cd36df6293f9\solver-1\text\D03.txt
- D:\Dev\Docket\tasks\aq-01322\runs\q01-r0-v2-e9943e281c4c3ad83064f87cbd3df1e814b37a90c5c548a257d5cd36df6293f9\solver-1\text\D05.txt
- D:\Dev\Docket\tasks\aq-01322\runs\q01-r0-v2-e9943e281c4c3ad83064f87cbd3df1e814b37a90c5c548a257d5cd36df6293f9\solver-1\text\D06.txt
